Isotopia Molecular Imaging and ARTMS announced the company's prostate-specific membrane antigen-11-based radiopharmaceutical has undergone has undergone multicurie labeling using cyclotrons. The radiolabeled kit demonstrated and radiochemical purity and six-hour stability
Isotopia, ARTMS collaboration produces PSMA-11 in cyclotron
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.